SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1952He shouldn't say stuff like this to the press: Momenta’s copies won’t needrkrw-3/11/2009
1951Obama Plan to Copy Biotech Drugs May Get Early Push (Update2) By Catherine Larkmopgcw-3/11/2009
1950siliconinvestor.comDewDiligence_on_SI-2/27/2009
1949I believe this might be the first shares he's sold since becoming ceo.rkrw-2/26/2009
1948Et Tu Craig Wheeler! sec.govghmm-2/26/2009
1947Working hard preparing for launch but insiders continue with their selling plansrkrw-2/25/2009
1946SeekingAlpha: MNTA Q4 2008 Earnings Call Transcript February 12, 2009 Executimopgcw-2/13/2009
1945On the Biosimilars front... reuters.com Novartis unit gets EU approval for genBiotech Jim-2/13/2009
1944About 2/3rds of Lovenox sales in the US, looks like a shade over $2B for the yearkrw-2/11/2009
1943From the sanofi-aventis group quarterly report and 2009 guidance: In 2009, sanoBiotech Jim-2/11/2009
1942<i>DD! Is MNTA one of your favorites?</i> Yes, it is—that’s why I mDewDiligence_on_SI-2/9/2009
1941DD! Is MNTA one of your favorites? average? tiamlkr-2/9/2009
1940Update on Lovenox patent: siliconinvestor.comDewDiligence_on_SI-1/29/2009
1939That’s what the GS analyst should’ve told him :-)DewDiligence_on_SI-1/26/2009
1938<i>ReadMeFirst</i> updated for new section on competition in MS (incDewDiligence_on_SI-1/26/2009
1937They filed nearly 6 years ago. The fda could always just tell them no if they prrkrw21/26/2009
1936<i>Were those comments specifically made about lovenox or just general comDewDiligence_on_SI-1/26/2009
1935Were those comments specifically made about lovenox or just general comments?rkrw-1/26/2009
1934Why processing of the Lovenox ANDA’s is so slow: siliconinvestor.comDewDiligence_on_SI-1/26/2009
1933Re: SeekingAlpha and plagiarism <i>[Mike Havrilla] should still cite his DewDiligence_on_SI-1/5/2009
1932if he did, he should still cite his sources/references...mopgcw-1/5/2009
1931Addendum on Christine Mundkur: She is 39 and a lawyer. At Barr, she headed the gDewDiligence_on_SI-1/5/2009
1930Mike Havrilla’s article is taken from the ReadMeFirst primer I maintain on iHub;DewDiligence_on_SI-1/5/2009
1929Today, NVS picked Christine Mundkur to be the head of Sandoz’s operations in theDewDiligence_on_SI-1/5/2009
1928From SeekingAlpha: Momenta Pharma's Opportunities Abound by: Mike Havrilla Jmopgcw-1/5/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News